Product
소개
RarePlex® PD-L1 CTC Panel Kit
Immunoflurescent Detection of PD-L1 expression by circulating tumor cells.
RareCyte’s programmed death ligand 1 (PD-L1) circulating tumor cell assay provides highly accurate, repeatable, and precise results for circulating tumor cell count and PD-L1 biomarker expression, and is suitable for use in large, multi-center clinical trials. The assay includes processing blood to slides with the AccuCyte® Sample Preparation System followed by staining with the RarePlex 0912-VB PD-L1 CTC Panel Kit and imaging on a CyteFinder® Instrument. Machine learning enabled analysis and scoring maximizes reviewer concordance.
This PD-L1 assay is deployed on RareCyte’s circulating tumor cell analysis platform with:
• Simple processing of blood to slides for sample banking
• Convenient pause points in workflow enable sample control and transport
• Flexibility in sample handling – processing and analysis may be performed at the same site or at a separate clinical research
laboratory when desired
• Extensive validation and highly automated process yield accurate and highly reproducible results
• Worldwide network of contract research organizations (CROs) to support global clinical trials
주문정보
RareCyte RarePlex PD-L1 CTC Panel Kit,Ventana (SYTOX) 24-1280-002
This 4- channel kit (Version: 0912-VB) detects PD-L1 in CTCs. The kit contains a nuclear dye and antibodies detecting CD45 (to exclude WBC), CK, EpCAM and PD-L1. Samples are stained by Ventana®DISCOVERY® ULTRA and imaged on CyteFinder®.
RareCyte RarePlex SW 900 spike-in CTC Control Slide, 10-Pack 24-1286-000
Contain monolayer of buffy coat and spiked-in SW 900 cells. Compatible kit: 24-1280-002.
RareCyte RarePlex BT-474 spike-in CTC Control Slide, 10-Pack 24-1247-000
Contain monolayer of buffy coat & spiked-in BT-474 cells. Compatibility: 24-1257-002,24-1245-002, 24-1245-001, 24-1277-002, 24-1277-001, 24-1277-004, 24-1280-002, 28-1001-481, 28-1001-401, 28-1001-402, 28-1001-482